Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115095
Chunk: 38

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 38
---
 | Up to 1,402,955 Private Warrants. |

| Redemption | The SPAC Warrants are redeemable in certain circumstances. See “Description of Our Securities — Public Warrants” “Description of Our Securities — Private Warrants” for further discussion. |

| Use of proceeds | We will not receive any proceeds from the sale of shares of Common Stock or Private Warrants by the Selling Securityholders, except with respect to amounts received by us upon the exercise of the Private Warrants for cash. |

| Market for our Common Stock and Public Warrants | Our Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX”. Our Public Warrants are listed on the Nasdaq Capital Market under the symbol “SCLXW”. |

| Risk factors | See “Risk Factors” beginning on page 23 and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in the securities being offered by this prospectus. |

| (1) | The number of shares of Common Stock outstanding assumes that an aggregate of 6,951,671 shares are outstanding immediately prior to the completion of this offering, which number is based on an aggregate of 6,951,671 shares outstanding as of December 31, 2024, taking into account the Reverse Stock Split, with no additional shares of Common Stock issued after December 31, 2024 and on or prior to March 31, 2025, and excludes: |

| • |     | 18,665 shares of Common Stock issuable upon the exercise of stock options outstanding under the 2017 Scilex Pharmaceuticals Inc. Equity Incentive Plan (the “Scilex Pharma 2017 Plan”) with a weighted average exercise price of $26.95 per share; |

| • |     | 432,087 shares of Common Stock issuable upon the exercise of stock options outstanding under the 2019 Stock Option Plan of Scilex, Inc. (the “2019 Stock Option Plan”) with a weighted average exercise price of $60.55 per share; |

| • |     | 571,738 shares of Common Stock issuable upon the exercise of stock options outstanding under the Scilex Holding Company 2022 Equity Incentive Plan (the “Equity Incentive Plan”), with a weighted average exercise price of $200.55 per share; |

| • |     | up to 494,662 shares of Common Stock available for future issuance